E

Exprivia SpA
MIL:XPR

Watchlist Manager
Exprivia SpA
MIL:XPR
Watchlist
Price: 1.52 EUR -12.14% Market Closed
Market Cap: 78.9m EUR
Have any thoughts about
Exprivia SpA?
Write Note
Section:
 

Relative Value

The Relative Value of one XPR stock under the Base Case scenario is 2.95 EUR. Compared to the current market price of 1.52 EUR, Exprivia SpA is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XPR Relative Value
Base Case
2.95 EUR
Undervaluation 48%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
23
vs Industry
88
Median 3Y
0.4
Median 5Y
0.4
Industry
2.3
Forward
0.4
More Details
6
P/E
P/E
Price to Earnings
6
vs History
31
vs Industry
49
Median 3Y
6
Median 5Y
5.6
Industry
22.8
Forward
5.8
More Details
4.6
P/OCF
P/OCF
Price to OCF
4.6
vs History
47
vs Industry
58
Median 3Y
5.2
Median 5Y
4.7
Industry
16.6
More Details
8.6
P/FCFE
P/FCFE
Price to FCFE
8.6
vs History
50
vs Industry
43
Median 3Y
11.2
Median 5Y
9.3
Industry
21.4
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
57
vs Industry
77
Median 3Y
0.9
Median 5Y
0.9
Industry
2.8
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
50
vs Industry
86
Median 3Y
0.4
Median 5Y
0.4
Industry
2.3
Forward
0.4
More Details
0.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.4
vs History
47
vs Industry
89
Median 3Y
0.4
Median 5Y
0.4
Industry
4.8
More Details
2.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
2.5
vs History
58
vs Industry
56
Median 3Y
2.8
Median 5Y
2.7
Industry
12.8
Forward
2.5
More Details
3.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
3.2
vs History
58
vs Industry
50
Median 3Y
3.6
Median 5Y
3.6
Industry
16.4
Forward
3.1
More Details
4.1
EV/OCF
EV/OCF
Enterprise Value to OCF
4.1
vs History
65
vs Industry
57
Median 3Y
5.4
Median 5Y
4.8
Industry
15.6
More Details
4.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
4.2
vs History
68
vs Industry
48
Median 3Y
5.6
Median 5Y
5.4
Industry
18.5
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
63
vs Industry
83
Median 3Y
0.5
Median 5Y
0.5
Industry
2.4
More Details

Multiples Across Competitors

XPR Competitors Multiples
Exprivia SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Exprivia SpA
MIL:XPR
78.9m EUR 0.4 6 2.5 3.2
US
Salesforce Inc
NYSE:CRM
283.4B USD 7.8 50.3 26.5 40.3
DE
SAP SE
XETRA:SAP
251.6B EUR 7.7 94.9 29 34.2
US
Adobe Inc
NASDAQ:ADBE
216.1B USD 10.4 40.3 25.5 28.4
US
NCR Corp
LSE:0K45
173.6B USD 22.9 -252.3 193.4 359.2
US
Intuit Inc
NASDAQ:INTU
171.9B USD 10.6 58 37.5 45.2
US
Palantir Technologies Inc
NYSE:PLTR
113.4B USD 45.8 280.4 336.5 374.6
US
Synopsys Inc
NASDAQ:SNPS
81.3B USD 13.4 54.2 46.3 54
US
Cadence Design Systems Inc
NASDAQ:CDNS
80.5B USD 18.5 77.4 55.5 63.4
CA
Constellation Software Inc
TSX:CSU
90.2B CAD 7 100 27.2 50.4
US
Workday Inc
NASDAQ:WDAY
64B USD 8.1 41.5 94.1 175.1

See Also

Summary
XPR intrinsic value, competitors valuation, and company profile.
DCF Valuation
XPR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XPR stock valuation using valuation multiples.
Wall Street Estimates
XPR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XPR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 194,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.